Matthew P. Young

Insider Reports History

Entity
Individual
Location
C/O Jazz Pharmaceuticals Plc, 5 Th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4, Ireland
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Matthew P. Young
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew P. Young:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Director Stock Option (Right to Buy) 38K May 15, 2024 Direct
PRA Health Sciences, Inc. Director Common Stock 0 $169.75 Jul 1, 2021 Direct

Insider Reports Filed by Matthew P. Young

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTMX CytomX Therapeutics, Inc. May 15, 2024 1 $0 4 May 17, 2024 Director
CTMX CytomX Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
CTMX CytomX Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
PRAH PRA Health Sciences, Inc. Jul 1, 2021 1 $0 4 Jul 1, 2021 Director
CTMX CytomX Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
PRAH PRA Health Sciences, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director